Publikation

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

Wissenschaftlicher Artikel/Review - 01.06.2018

Weyerbrock Astrid